AltRx Annual GLP-1 Plan: Prepayment, Savings and Cancellation Terms

Last reviewed: September 4, 2026 Last updated: September 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

AltRx offers a promotional 12-month prepaid plan at $75 per month for compounded semaglutide ($900 upfront) and $125 per month for compounded tirzepatide ($1,500 upfront), advertised through September 5, 2026. The platform states "cancel anytime," but a Trustpilot review captured September 4, 2026 alleges a full annual prebill despite selecting month-to-month service. Standard rates after the promotional deadline are not documented. The 12-month semaglutide total ($900) undercuts PlexusDx's 6-month commitment rate ($149/month, $1,788 annually), but the comparison requires $900 paid up front versus PlexusDx's month-to-month billing at the commitment rate. Readers evaluating the AltRx annual plan should confirm cancellation mechanics, refund terms, and post-promotional pricing at checkout.

At-a-glance comparison

AltRx figures captured September 4, 2026; promotional pricing advertised through September 5, 2026. PlexusDx figures current as of September 4, 2026. Twelve-month totals are our calculation.

Breaking down AltRx's prepaid plan tiers

AltRx structures its GLP-1 pricing around four promotional tiers for both compounded semaglutide and tirzepatide, each requiring a larger upfront commitment in exchange for a lower effective monthly rate. The promotional rates expire September 5, 2026; standard ongoing rates after that date are not documented in the captured evidence.

Semaglutide pricing tiers (promotional, ends September 5, 2026)

• Monthly billing: $89 per month, no upfront payment—$1,068 total over 12 months (our calculation).
• 3-month prepaid: $255 upfront, $85 per month—$1,020 total over 12 months (our calculation, $255 × 4 quarters).
• 6-month prepaid: $480 upfront, $80 per month—$960 total over 12 months (our calculation, $480 × 2 half-years).
• 12-month prepaid: $900 upfront, $75 per month—$900 total over 12 months.

The annual plan saves $168 compared to AltRx's own monthly billing option over 12 months (our calculation, $1,068 − $900).

Tirzepatide pricing tiers (promotional, ends September 5, 2026)

• Monthly billing: $149 per month, no upfront payment—$1,788 total over 12 months (our calculation).
• 3-month prepaid: $432 upfront, $144 per month—$1,728 total over 12 months (our calculation, $432 × 4 quarters).
• 6-month prepaid: $780 upfront, $130 per month—$1,560 total over 12 months (our calculation, $780 × 2 half-years).
• 12-month prepaid: $1,500 upfront, $125 per month—$1,500 total over 12 months.

The annual plan saves $288 compared to AltRx's own monthly billing option over 12 months (our calculation, $1,788 − $1,500).

All tiers include medical oversight, medication, support, shipping, and consultation at the stated price. AltRx charges no separate membership fee. The same price applies at all doses for a given medication.

Comparing AltRx's annual plan to PlexusDx pricing

PlexusDx does not offer a 12-month prepaid plan. The closest structural analog is the 6-month commitment tier, which bills monthly at the commitment rate rather than requiring upfront payment.

Semaglutide: 12-month cost comparison

• AltRx 12-month prepaid (promotional): $900 upfront, $75 per month, $900 total over 12 months.
• PlexusDx 6-month commitment: $149 per month billed monthly, $1,788 total over 12 months (our calculation, $149 × 12).
• PlexusDx month-to-month: $189 per month, $2,268 total over 12 months (our calculation, $189 × 12).

AltRx's promotional annual plan delivers $888 in savings over PlexusDx's 6-month commitment rate (our calculation, $1,788 − $900) and $1,368 over PlexusDx's month-to-month rate (our calculation, $2,268 − $900). The comparison requires $900 paid at enrollment versus PlexusDx's monthly billing.

Tirzepatide: 12-month cost comparison

• AltRx 12-month prepaid (promotional): $1,500 upfront, $125 per month, $1,500 total over 12 months.
• PlexusDx 6-month commitment: $249 per month billed monthly, $2,988 total over 12 months (our calculation, $249 × 12).
• PlexusDx month-to-month: $289 per month, $3,468 total over 12 months (our calculation, $289 × 12).

AltRx's promotional annual plan delivers $1,488 in savings over PlexusDx's 6-month commitment rate (our calculation, $2,988 − $1,500) and $1,968 over PlexusDx's month-to-month rate (our calculation, $3,468 − $1,500). The comparison requires $1,500 paid at enrollment versus PlexusDx's monthly billing.

These comparisons use AltRx's promotional rates advertised through September 5, 2026. Standard rates after the promotional deadline are not documented and should be confirmed at checkout.

The cancellation-terms conflict

AltRx advertises "cancel anytime" on its promotional landing page (captured September 4, 2026). A Trustpilot review posted September 4, 2026 alleges "a full annual prebill despite selecting month-to-month" service. The same allegation appears in a Reddit thread. The evidence does not document AltRx's refund policy, cancellation process, or whether prepaid amounts are prorated or refunded upon early termination.

Readers considering the 12-month prepaid plan should confirm at checkout whether the $900 (semaglutide) or $1,500 (tirzepatide) upfront payment is refundable or prorated if treatment is discontinued before the 12-month period ends, and whether "cancel anytime" applies to billing obligation or only to medication shipment. The promotional landing page does not specify these terms.

What the prepaid annual plan offers

• Lower effective monthly rate: $75/month semaglutide or $125/month tirzepatide (promotional, through September 5, 2026), the lowest per-month rate in AltRx's pricing grid.
• Fixed cost over 12 months: $900 (semaglutide) or $1,500 (tirzepatide) locks in the total treatment cost for one year, insulating from potential rate increases during that period.
• All-inclusive service: Medical oversight, medication, shipping, consultation, and support included at the stated price; no separate membership fee.
• Same price at all doses: The monthly rate does not increase with dose escalation during the 12-month period.

What the prepaid annual plan requires

• Full upfront payment: $900 (semaglutide) or $1,500 (tirzepatide) due at enrollment; no installment option documented.
• 12-month commitment: The savings depend on completing the full year; early discontinuation economics are unclear without documented refund terms.
• Promotional deadline: The advertised rates expire September 5, 2026; standard rates after that date are not documented.
• Cancellation-term uncertainty: The conflict between "cancel anytime" messaging and a Trustpilot allegation of annual prebilling requires clarification at checkout.
• Medication type: Compounded semaglutide and tirzepatide only; branded Wegovy, Zepbound, and Ozempic are listed on the site but pricing is not documented in the captured evidence.

Choose AltRx's annual plan if…

• You can afford $900 (semaglutide) or $1,500 (tirzepatide) upfront and prefer to pay once rather than manage monthly billing.
• You are confident in a 12-month treatment commitment and want the lowest effective monthly rate advertised by AltRx during the promotional period.
• You can enroll before the September 5, 2026 promotional deadline.
• You are comfortable confirming refund and cancellation terms directly with AltRx at checkout, given the documented conflict between "cancel anytime" messaging and a Trustpilot report.

Choose PlexusDx if…

• You prefer month-to-month billing with no upfront payment—PlexusDx bills the commitment rate monthly rather than requiring a lump sum.
• You want flexibility to discontinue without financial exposure beyond the current billing cycle (month-to-month plan) or the commitment period (3-month or 6-month plan).
• You value a documented review record—PlexusDx holds a 4.2-star rating on Trustpilot, with 76% of reviews at five stars and 81% at four stars or higher (captured September 4, 2026).
• You want to evaluate treatment response before committing to a full year, using PlexusDx's month-to-month option or a shorter 3-month or 6-month commitment.
• You prefer transparent, published pricing with no promotional deadlines or expiration dates.

Methodology and freshness

All AltRx pricing, plan terms, and promotional deadline details were captured from the platform's public promotional landing page (https://www.altrx.com/glp1/offer-v9-fl) and product pages on September 4, 2026 at 13:49:55 UTC. The Trustpilot review allegation was captured September 4, 2026. PlexusDx pricing is current as of September 4, 2026. Twelve-month cost totals and savings calculations are our calculation, derived from the advertised per-month rates or upfront prepaid amounts. AltRx's standard rates after the September 5, 2026 promotional deadline are not documented in the captured evidence; readers should confirm current pricing at checkout. The prepayment structure for AltRx's multi-month plans is inferred from the upfront dollar amounts presented on the promotional page; checkout-level billing verification was not captured. Refund and cancellation-process details are not documented in the evidence.

Frequently Asked Questions

Does AltRx's 12-month plan refund unused months if I stop early?

The captured evidence does not document AltRx's refund policy. AltRx advertises "cancel anytime," but a Trustpilot review alleges a full annual prebill. Confirm at checkout whether the $900 (semaglutide) or $1,500 (tirzepatide) upfront payment is refundable or prorated if you discontinue before 12 months.

What happens to AltRx pricing after September 5, 2026?

All documented AltRx rates are promotional and advertised through September 5, 2026. Standard ongoing rates after the promotional deadline are not documented in the captured evidence. Readers enrolling after that date should confirm current pricing at checkout.

Does PlexusDx require any upfront payment for multi-month commitments?

No. PlexusDx bills the commitment rate monthly—$149/month for semaglutide on a 6-month commitment, $249/month for tirzepatide on a 6-month commitment. You pay each month, not upfront. The commitment affects the per-month rate, not the billing method.

Can I switch from semaglutide to tirzepatide mid-commitment on either platform?

The captured evidence does not document medication-switching terms for AltRx or PlexusDx multi-month plans. Switching typically requires a new clinical evaluation and may affect plan pricing. Confirm switching terms with the provider before enrolling.

Are the medications compounded or FDA-approved branded drugs?

The documented AltRx pricing applies to compounded semaglutide and tirzepatide injections. AltRx lists Wegovy, Ozempic, and Zepbound on its site, but pricing for those branded medications is not captured. PlexusDx offers compounded semaglutide and tirzepatide. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Sources

• AltRx promotional landing page (https://www.altrx.com/glp1/offer-v9-fl), accessed September 4, 2026
• AltRx compounded tirzepatide product page (https://www.altrx.com/products/compounded-tirzepatide), accessed September 4, 2026
• Trustpilot review (individual report), accessed September 4, 2026
• PlexusDx Trustpilot profile, accessed September 4, 2026
• PlexusDx pricing (https://plexusdx.com/products/semaglutide-injection, https://plexusdx.com/products/tirzepatide-injection), accessed September 4, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.